Skip to content

    Vinyas Innovativ

    VINYAS
    Capital Goods·4 Jun 2025
    Management Summary

    Vinyas Innovative Technologies Ltd. reported a strong FY25, with revenue growing 25% to ₹396.6 crores and PAT increasing 27% to ₹19.4 crores. The company secured ₹737 crores in new orders, building a robust order book of ₹1,018 crores. While H2 FY25 saw exceptional revenue growth, supply chain disruptions led to a temporary increase in receivables and inventory, which management expects to normalize.

    Highlights

    5
    • FY25 Revenue grew 25% YoY to ₹396.6 crores, demonstrating robust top-line expansion.

    • EBITDA for FY25 increased 22% to ₹44.4 crores, with margins maintained at 11%.

    • Net Profit (PAT) for FY25 rose 27% to ₹19.4 crores, indicating strong profitability.

    • The company booked ₹737 crores in new orders during FY25, leading to a substantial order book of ₹1,018 crores as of May 30, 2025.

    • Net worth increased to ₹147 crores from ₹128 crores, reflecting a strong capital base.

    Concerns

    2
    • Receivables and inventory saw a sharp jump at year-end due to supply chain disruptions from the Middle Eastern conflict and dependency on Israeli supply chain for 27-30% of programs.

    • H2 FY25 margins were slightly lower due to a mixed change, with a larger volume of slightly lower margin boards contributing to revenue.

    What Changed2

    vs Q2 FY26

    Guidance items9 → 8 (-1)Risks discussed1 → 3 (+2)
    Key financials

    Metrics

    11

    Periods

    2

    Headline

    5
    • H2 FY25 Revenue
      ₹247.1 Cr
      YoY+37%
    • H2 FY25 EBITDA
      ₹26.7 Cr
      YoY+32%
    • H2 FY25 EBITDA Margin
      11%
    • H2 FY25 PAT
      ₹12.4 Cr
      YoY+28.0%
    • H2 FY25 EPS
      ₹9.86

    FY25

    6
    • Revenue
      ₹396.6 Cr
      YoY+25%
    • EBITDA
      ₹44.4 Cr
      YoY+22%
    • EBITDA Margin
      11%
    • PAT
      ₹19.4 Cr
      YoY+27%
    • EPS
      ₹15.43

    Segment breakdown

    Defense and Aerospace
    78% Revenue Contribution
    Industrial
    18.4% Revenue Contribution
    Medical Devices
    ₹6.7 Cr Revenue
    Other Segments
    ₹7.5 Cr Revenue
    List

    Order Book

    high confidence

    Total Value

    ₹ 1,018 crores

    as of 2025-05-30

    quantified

    Execution

    The order book execution is over the next 12 to 18 months. It's a mix between some of it executing in 12 months, some of it executing over the next 18 months. So, the longest period is about 18 months.

    Composition

    Mix3 client types
    • Defense80.0%
    • Industrial18.0%
    • Medical2.0%

    Share of order book by client type

    Pipeline

    other

    Opportunity pipeline over next 4-5 years

    "The company has a strong order book with good visibility, supported by new order wins and a significant long-term opportunity pipeline."

    Source:
    Prepared remarks

    Capital allocation

    2
    medium confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Liquidity

    Liquidity disclosed

    Sufficient unutilized non-fund based limit with the bank to support working capital requirements for the current and next financial year.

    Guidance & targets

    8
    CategoryTargetPriority
    Revenue
    Revenue Growth
    25%
    High
    Revenue
    Revenue Potential with Current Capacity
    ₹1,200 to ₹1,400 crores
    Medium
    Margin
    EBITDA Margin
    9% to 11%
    High
    Margin
    Margin Profile
    9% to 11%
    High
    Order Inflow
    Order Inflow
    ₹600 to ₹750 crores
    High
    Order Book
    Order Book
    ₹1,500 to ₹1,600 crores
    High
    Capacity
    Optimal Capacity Utilization
    Full
    High
    Working Capital
    Working Capital as % of Revenue
    30%
    High

    Order Book Growth

    by end of FY26
    Current₹1,018 crores as of May 30, 2025
    Target₹1,500 to ₹1,600 crores

    Why it matters

    Tracking the growth of the order book is crucial for future revenue visibility and execution.

    So, with a 25% growth this year, we expect the confirmed order book to grow to about Rs. 1,500 crores to Rs. 1,600 crores by the end of this financial year.

    How to verify

    order_book.value.amount

    Risks & concerns

    3
    RiskSeverity

    Delays in defense programs

    Major risk for the ₹9,000-10,000 crore opportunity pipeline, leading to push-outs in sanctioning and reaching manufacturing stages.Management acknowledged

    high

    Supply chain disruptions and dependency on Israeli suppliers

    Middle Eastern conflict caused fluctuations in supply chain, impacting receivables and inventory, with 27-30% of programs having dependency on Israeli supply chain.Management acknowledged

    medium

    Raw material cost volatility

    Raw material costs are significantly higher, though the company has protections like BOM price parity and foreign exchange rate variation for most programs.Management acknowledged

    low

    Q&A highlights

    8

    “So, Piyush, we are what we call as a high-mix, high-complexity assembly house. So, we make critical subsystems for our customers. And we focus on fairly complex both PCB assemblies as well as system assemblies for our customers. And we focus on low and medium volume manufacturing. So, that is what we are focused on, and that is the differentiating factor for Vinyas.”

    Clarifies Vinyas's niche and competitive advantage in the EMS sector, distinguishing it from high-volume manufacturers.

    asked by Piyush Arora

    3 min read7 chapters

    Detailed Narrative

    01

    Strong Financial Performance in FY25 and H2 FY25

    Vinyas Innovative Technologies Ltd. delivered a robust performance in FY25, with total revenue reaching ₹396.6 crores, marking a 25% year-on-year growth from ₹317 crores in FY24. EBITDA stood at ₹44.4 crores, up 22%, maintaining an 11% margin. Net profit (PAT) grew by an impressive 27% to ₹19.4 crores. The second half of FY25 was particularly strong, contributing ₹247.1 crores in revenue, a 37% growth over the same period last year, with H2 EBITDA at ₹26.7 crores (32% growth) and PAT at ₹12.4 crores (28% growth).

    02

    Robust Order Book and Future Visibility

    The company booked ₹737 crores in new orders from domestic and global customers during FY25. As of May 30, 2025, the total order book stands at ₹1,018 crores, with an execution timeline of 12 to 18 months. Management expects order inflow for FY26 to be between ₹600 to ₹750 crores, projecting the confirmed order book to grow to ₹1,500-₹1,600 crores by the end of FY26. A long-term opportunity pipeline of ₹9,000-₹10,000 crores over the next 4-5 years further enhances future visibility.

    03

    Strategic Focus on High-Reliability Electronics and Segment Contributions

    Vinyas specializes in high-mix, high-complexity assembly for mission-critical and safety-critical applications, operating on build-to-print and build-to-spec models. The Defense and Aerospace segment remains dominant, contributing 78% of the revenue. The Industrial segment showed remarkable growth, contributing 18.4%, while medical devices contributed ₹6.7 crores and other segments ₹7.5 crores. The company has also made an entry into the commercial aerospace manufacturing segment.

    04

    Capacity Expansion and Utilization Outlook

    The company's manufacturing facility in Mysore spans 1,50,000 square feet and is equipped with advanced SMT lines. Currently operating at approximately 35% capacity, it has the potential to generate ₹1,200-₹1,400 crores in revenue. Management anticipates achieving full optimal utilization of the facility by FY27, with a 25% year-on-year growth target for FY26.

    05

    Working Capital Management and Supply Chain Resilience

    FY25 saw a positive operating cash flow of ₹8.8 crores. However, receivables and inventory increased at year-end due to supply chain disruption🌐s stemming from the Middle Eastern conflict, particularly due to a 27-30% dependency on the Israeli supply chain. Management expects these issues to smoothen out in Q1 FY26 and aims to bring working capital as a percentage of revenue down to a target of 30% over the next two to three years.

    06

    Export Market Penetration and Localization Initiatives

    Export orders now constitute 22-23% of the company's total orders, driven by localization requirements for medical devices under a 'China plus One' strategy and necessary certifications for defense programs. The company is actively participating in critical defense programs, positioning itself to capitalize on India's emergence as a global defense electronic hub.

    07

    Operational Efficiencies and Margin Outlook

    Vinyas maintains an EBITDA margin of around 11%, which management expects to remain stable within the 9-11% range for the next 2-3 years. While H2 FY25 experienced slightly lower margins due to a mixed change towards lower-margin boards, the company is focused on operational efficiencies. Becoming a full product/subsystem integrator is expected to expand gross margins by 2-3 basis points.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.